Purchase Order HHSN272201600404P
Award Date 3/8/16
Potential Completion Date 3/31/17
Potential Value $101K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The $3,504.92 award is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. Illumina has a history of providing these types of goods and services to federal...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions, for the provision of 11 reagent kits and lab consumables. The order, valued at $42,166.99, was placed without any set-aside designation and supports the agency's research and diagnostic efforts in the life sciences domain. Illumina has a...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $48,000.00. The award is to provide service and support for Illumina's Genome Analyzer Illumina sequencing systems. Illumina is a manufacturer and provider of genetic and genomic sequencing and analysis instruments and reagents. This award does not have a set-aside designation. Illumina has a history of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions, for Illumina reagents and consumables. The contract has a potential value of $219,355.66 and a completion date of May 20, 2019. There was no set-aside used for this award. Illumina has previously provided sequencing systems,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for $105,341.32. The order includes various sequencing products such as the NovaSeq 6000 S2 Reagent Kit, NovaSeq XP 2-Lane Kit, MiSeq Reagent Kit V2, and Nextera XT DNA Library Preparation Kit to support life science research, applied...
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Illumina, Inc. The $5,006.36 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services and support to support genomic sequencing and analysis, with no set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and solutions, and...
- The U.S. Department of Health and Human Services National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,753.75 firm fixed-price delivery order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The award is not designated as a set-aside contract. Through this order, Illumina will provide biosequencing materials to support NIAID's biomedical research activities. Illumina has previously received prime federal contracts and subcontracts...
- This $20,641.23 firm fixed price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract provides Illumina reagents and consumables to support the agency's genomic research and analysis work. Illumina has a history of providing sequencing equipment and related products and services to various federal agencies, including...